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Explanatory  Memorandum 
A.  General  observations 
1.  The  proposed  directive  has  as  Its objective  to  ensure 
that  precursor  chemicals  are  not  diverted  to  the 
Illicit  manufacture  of  drugs  and  that  there  are  not 
distortions  of  competition  In  the  licit  manufacture 
2. 
and  placing  on  the  CommunIty  market  of  these 
chemicals.  To  this  end  the  proposed  directive  alms  to 
lay  down  measures,  as  reQuired  by  the  1988  UN 
Convention,  to  monitor  the  manufacture  and  placing  on 
the  Community  market  of  precursors  of  psychotropic 
and  narcotic  substances.  The  1988  UN  Convention 
against  Illicit  trafficking  In  Narcotic  drugs  and 
psychotropIc  substances  was  sIgned  by  the  CommunIty 
on  8  June  1989.  This  directive  also  complements  the 
monitoring  of  Community's  external 
precursors  as  foreseen  by  the  parallel 
Councl I  regulation* 
The  substances  concerned  are  chemicals, 
trade  In 
proposed 
some  of 
limited  I I cIt  trade  (Annex  Table  I)  others  of 
substantial  licit  trade  (Annex  Table  I I).  These  are 
used  as  pharmaceutical  Intermediates  or  are  chemicals 
either  solvents  and/or  acids  which  are  legitimately 
used  In  a  wide  range  of  chemical  outlets.  They  are 
als.o  Important  In  the  refining  and  processing  of 
drugs  and  for  this  reason  can  be  considered  as 
'precursor  chemicals  to  the  Illicit  manufacture  of 
narcotic  drugs  and  psychotropic  substances. 
*  COM  (90)  215  20.06.1990 
Proposal  for  a  Council  Regulation  laying  down  measures  to 
be  taken  to  discourage  the  diversion  of  certain 
substances  to  the  I I II cIt  manufacture  of  narcotIc  drugs 
and  psychotropic  substances - 2  -
3.  Monitoring  of  precursors  worldwide  and  particularly 
4. 
In  countries  wIth  a  highly  developed  chemical 
Industry  Is  considered  a  necessary  means  of 
discouraging  manufacture  and  I I mIt I ng  supply  of 
Illicit  drugs  and  as  such  received  primary  attention 
In  the  Global  Plan  of  Action  adopted  by  the  UN 
General  Assembly  on  23  February  1990.  Adoption  of 
measures  to  monitor  precursors  has  been  recognized  by 
CELAD  In  Its  report,  endorsed  by  the  June  1990  Dublin 
Council,  as  one  of  the  priority  Items  In  Community 
anti-drug  action  In  the  context  of  a  single  market. 
The  proposed  directive  foresees,  as  required  by  Art. 
12  of  the  UN  Convention,  that  operators  maintain 
comprehensive  commercial  records  of  all  transactions 
In  the  scheduled  substances,  except  for  minor 
quantities  of  solvents  and  acids  sold  at  retai I 
I eve I.  In  addition  the  essential  pharmaceutical 
Intermediate  chemicals  (Annex  Table  I  )  w I  I  I  be 
requ 1 red  to  be  manufactured  or  pI aced  on  the  market 
by  and  to  operators  possessing  an  authorization.  As 
the  overwhelming  proportion  of  the  legitimate 
transactions  In  Table  products  are  for 
pharmaceutical  end-uses  the  authorization  procedure 
foreseen  makes  use  of  the  existing  authorization 
system  for  the  manufacture  of  pharmaceut I ca Is. 
need  to  obtain  the  fullest  cooperation  of 
The 
the 
concerned  economic  operators  to  ensure  efficacy  of 
mo~ltorlng  precursors  Is  also  recognized.  In  due 
consideration  of  areas  covered  by  Member  States' 
competence  the  proposal  I  I mIt s  Itself  to  the 
Identification  of  certain  objectives  to  be  met  by 
national  legislation. 
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B.  Contents  of  the  Directive 
1 .  In  conformity  with  the  UN  Convention,  the  proposed 
directive  distinguishes  between  two  types  of 
precursors  (cf  Table  I  and  Table  II  In  the  Annex), 
I.e.  those  with  limited  use  for  licit  purposes  (Table 
substances)  and  others  with  essential  Importance 
for  legitimate  commercial  use  (Table  II  substances). 
Both  categor les  of  precursors  are  subject  to  the 
general  monitoring  scheme  laid  down  In  this  directive 
whereas  the  more  stringent  measures  of  Article  4 
apply  to  Table  1  substances  only1) 
2.  a)  Article  1  determines  the  scope  and  lays  down  a 
number  of  definitions  of  terms. 
b)  Article  2  lays  down  the  documentary  requirements 
and ·ensures  that  competent  authorItIes  read I I y 
obtain  access  to  documents  and  records  for 
verification  purposes  (9d,  e,  UNC). 
c)  Article  3  requires  Member  State•  to  appoint 
competent  authorities  for  alI  matters  relating  to 
the  Implementation  of  the  directive. 
d)  Article  4  (8a,  b  UNC)  establishes  an 
authorization  system  for  substances  of  Table 
that  makes  use  of  the  system  established  under 
Art  16  of  Directive  75/319/EEC. 
1)  Numbers  In  brackets  refer  to  corresponding  paragraphs  of 
Article  12  of  the  UN  Convention  (UNC) - 4  -
e)  Article  5  containing  the  centerpiece  of  the 
standard  monitoring  system  reflects  the 
cooperation-based  approach  by  stimulating 
economic  operators  as  wei I  as  other  persons 
professionally  Involved  to  Inform  authorities  of 
any  circumstance  Indicating  the  possibility  of 
diversion  (9  a  UNC) 
f)  Article  6  Intends  to  facilitate  the  application 
of  the  directive  by  supplying  monitoring 
authorities  with  sufficient  powers  such  as 
Inspection,  search  and  seizure  (9  b  UNC). 
g)  Article  7  covering  Intra-Community  cooperation 
between  monitoring  authorities  refers  mutatis 
mutandis  to  Regulation  (EEC}  1468/81  on  mutual 
assistance  In  customs  and  agricultural  matters, 
thus  providing  not  only  for  a  well-established 
mechanism  In  administrative  assistance  but  also 
for  due  protection of  confldendlallty  with  regard 
to  all  Information  obtained  and  circulated  under 
this  directive. 
h)  Final  provisions 
Article  8  whl le  avoiding  Interference  with  Member 
States'  competence  In  criminal  matters,  ensures 
that  Infringements  of  this  directive  be  subJect, 
Community-wide  to  appropriate  sanctions. 
:> - 5  -
Article  9  (12  UNc>2>  serves  to  fulfl.'l.the  annual 
reporting  obligations  towards  the  UN  with  the 
Commission  acting  as  coordinating  bod~. 
Article  10  requires  Member  States  to. r,eport  the 
Implementing  measures  adopted. 
2)  The  requirement.  to  supply  Information  on  nature  and 
o~~lgln  of  processing  equipment ·seized  ;Is  contained  In 
Art.  13  of  UNC. 
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Proposal  for  a 
·COUNCIL  PIBECTIYE 
on  the  manufacture  and  the  p~aclng on  the market  of 
certain substances used  In  the  l.lllcJt manufacture 
of  nar  cot I c  drugs and  psychotropIc_ substances  .  · 
---------------·---
THE  COI:JNCIL  OF  THE  EUROPEAN  COMMUNITIES, 
Having: regard  to  the Treaty  establishing  the  European  Economic  Community, 
and·  In particular Article 100a  thereof, 
Having  regard  to  the  proposal  from  the  Convnlsslon1, 
In cooperation .with  the .European Parltament2. 
ttavlng regard to the·oplnton-of  the  Economic  and Social  COnmlttee3, 
Whereas  some  Member  -Stat.es. _ have' · adopted  ..  measures  to  monItor  the 
manuf.acture  and  the placlng.on )the market of certain substances  freQuently.· 
used:  In  the  llltcl.t-manufacture  of  narco.t'tc  drugs  and  psychotropic 
· substances•  whereas  other  Member  States  are  about  to  adopt  measures  of 
.this  kind·;, whereas  It .Is· therefore  necessary  to establish  conmon  rules .at 
Communtty  -level  In  the. perspect..lve  of  the·  completed  Internal· market  In 
,::J  ........  ~  • 
order  to avot.d.dlstor.tlonof  competition  In  the  licit trade  and  to ensur:e.  , 
·homogenous  app 1 I cat I on of  the ru  1  es ,  est  ab I 1  stted  • · 
1 
2. 
3· .. 
.,..  3  -
Whereas  on  19  December  1988,  the  UnIted  Nations  Conference 
In  the  effort  to  combat  drugs  a  Convention  against~  adopted 
II  I I  cIt  Traffic  In  Narcotic  Drugs  and  Psychotropic- Substances; 
whereas  the  Community  participated  In  the  negot I  at ton  of  this 
Convention,  showing  Its  political  will  to  act  within  the  limits 
of  Its competences; 
Whereas  the  requirements  of  Article  12;  of  the  aforementioned 
Convention,  In  respect  of  trade  In  precursors,  I .e.  substances 
frequently  used  In  the  II licit  manufacture  of  narcotic  drugs  and 
psychotropIc  substances  are  Imp Iemen ted  as  far  as  trade  between 
the  Community  and  third  countries  by  Counc II  Regulation 
.  4 .  . . . . . . . . .  , 
Whereas  Article  12  of  the  convention  envisages  adoption  of 
appropriate  measures  to  monitor  manufacture  and  distribution  of 
precursors;  whereas  In  order  to  trace  possible  Illicit 
diversions  of  precursors  In  the  Community  or  In  view  of  a 
fraudulent  export  from  the  Community  and  to  ensure  that  common 
monitoring  rules  are  applied  In  the  Community  market,  It  Is 
necessary  to  complement  the  aforesaid  regulation; 
Whereas  the  provisions  of  Article  12  of  the  Convention  are  based 
on  a  system  of  monitoring  trade  In  the  substances  In  question; 
whereas  documentation  and  label I lng  as  regards  consignments  of 
these  substances  have  to  be  sufficiently  clear;  whereas  It  Is 
furthermore  Important,  wh list  providing  competent  authorities 
with  the  necessary  means  of  action,  to  develop,  In  comp I I  ance 
with  the  spirit  of  the  Convention,  mechanisms  which  are  based  on 
close  cooperation  with  the  economic  operators  concerned  as  well 
as  on  the  development  of  the  gathering,  exchange  and 
exploitation of  Intelligence; 
Whereas  It  Is  also  Important,  In  this  context,  that  Member 
States provide  for  sufficiently dissuasive sanctions; 
4 .  '· 
Whereas,  to 
measures  have 
- 4  -
uncover  I II !cIt  manufacture  and 
to  be  taken  to  encourage  vI  g I I ance ,  by 
dlstr  I button·, 
the  various 
oper!ltors,  In  respect  ·of  suspect  operatIons  and  the 1  r  detect Iori 
In cooperation with  the  competent  authorities; 
Whereas  the  I tclt  trade  In  scheduled  substances  In  Table  of 
the  Annex  Is  In  fact  restricted  to  the  manufacture  of  medicinal 
products;  whereas  It  Is  therefore  possible  to  limIt  the 
manufactur:e  and  use  of  these  products  to  persons  holding  an 
authorization  to  manufacture  medicinal  products  granted  In 
accordance  with  Article  16  of  Council  Directive  75/319/EEC  of 
20  May  1975  on  the  approximation  of  provisions  laid  down  by  law, 
·regulation  or  administrative  action  relating  to  proprietary 
medicinal  products5,  as  last  amended  by  Directive 89/381/EEC6; 
Whereas  It  Is  Important  to  provide  mechanisms  for  administrative 
cooperation;  whereas  It  Is  suitable  In  t"rrr-~~espect,  as  far  as 
the  competent  authorities  In  the  Community  ~~cerned,  to 
seek  lnsp 1  rat I on  from  Counc II  Regulat lon  ..  (EEC)  No  -~ata1'-·  .... ,nr 
19 May  1981  on  mutual  assistance  between  the  admlnl:R"t:-r:atlve 
• 
author 1  t les  of  the  Member  States  and  cooper at ton  betwe~ 
latter  and·  the  Commission  to  ensure  the  correct  application  of  ·~---.....-..~ 
the  taw  on  customs  and  agricultural 
Regulation  (EEC)  No  .  945/878;  whereas 
to  be  paid  to  the  confidentiality 
and  exchanged, 
·5 .OJ  No  L  U7  •  9~6.1975, p.  13.  ~ 
6  OJ  No  L  181.  28.6.1989,  P~ 44. 
7  OJ  No  L  144,. 2.6.1981,  p.  1. 
·a  OJ  No  L  90,  2. 4.1987,;  p.  3. 
of 
matters7,  as  amended  .bY 
particular,  attention  has 
'-~, 
the  lnforma~lon  received - 5  -
HAS  ADOPTED  THIS  DIRECTIVE 
TITLE 
General 
Article 
1.  This  Directive  concerns  the  monitoring,  within  ·the 
community,  of  certain  substances  freQuently  used  In  the 
I I I lclt  manufacture  of  narcotic  "drugs  and  ·psychotropic 
su~stances,  with  a  view  to  ·preventing  diversion  of  such 
substances. 
2.  For  the  purposes of  this Directive 
(a) 
(b) 
(c) 
"scheduled  substances"  means  any  substance  1 lsted 
In  the  Annex  Including  mixtures  containing  such 
substances.  This  excludes  pharmaceutical 
preparations  or  other  preparations  containing 
scheduled  substances  that  are  compounded  In  such  a 
way  that  such  substances  cannot  be  easl ly  used  or 
recovered  by  readIly appl lcable means; 
the 
free 
market"  means 
of  charge  to 
"placing  on 
payment  or 
scheduled  substances  manufactured 
any 
third 
In 
disposal 
parties 
the 
or  put  Into  free circulation  In  the Community; 
"operator"  means  any  natural  or  legal 
against 
of  the 
CommunIty 
person 
engaged  In  the  manufacture,  processing,  trade  or 
distribution  of  scheduled  substances  In  the 
Community,  or  Involved  In  other  related  activities 
such  as  broklng or  holding  stock  for  third parties; - 6  -
(d)  "UN  Convention"  means  the  UnIted  Nations  Convention 
against  llllc  It  traffIc  In  Narcotic  Drugs  and 
Psychotropic  Substances,  adopted  In  VIenna  on 
19  December  1988: 
(e)  "International  Narcotics  Control  Board"  means  the 
Board  estab I I  shed  by  the  Single  Convention  on 
Narcotic  Drugs  of  1961,  as  amended  by  the  1972 
Protocol. 
TITLE  II 
Monitoring of  placing on  the  market 
Article  2 
Documentation,  records  and  Iabeii lng 
Member  States  sha II  take  a II  the  measures  necessary  to  ensure 
that  the  placing  on  the  market  of  scheduled  substances  Is 
subject  to  the  following  requirements: 
1.  all  transactions  leading  to  the  placing  on  the  market  of 
scheduled substances shall  be  properly documented. 
(a)  In  particular,  commercial  documents  such  as 
manifests,  administrative  Invoices, 
documents, 
cargo 
transport  and  other  shipping  documents 
enable  shall  contain  sufficient  Information  to 
positive  Identification of  the  following; 
the  narneJ  the  qu~nt: ty  and  the 
scheduled 
or  In 
quantIty 
substance(s) 
the 
and 
case 
the 
rested  tn the Annex.-
as  stated 
of  ml xtures, 
weight  of 
walght  of  the 
the  Annex, 
name,  the 
In 
the 
the  substance(s) 
~ • 
2. 
..  ~. 
4. 
- 7  -
the  name  and  address  of  the  suppl ler(s) 
customer(s); 
and  the 
(b)  the  documentation 
declaration  from 
must 
the 
and 
furthermore 
customer  which 
contain 
shows 
a 
the 
specific  uses  which  confirms  .  that  these 
substances  are  not  used  for  the  I I I lclt  manufacture 
of  narcotic  drugs or  psychotropic substances. 
(C)  The  obi lgat~ons  under  (a)  and  (b)  shall  not  apply 
to  transactions  concerning  products  of  table  II  of 
not  the  Annex  when  the  quantities  Involved  do 
exceed  those  Indicated  In  Table  Ill  of  the  Annex. 
Whenever  operators  app I  y  · I  abe 1  s  , to  scheduled  substances 
In  order  to  place  ·them  on  the  market  such  I  abe Is  sha I I 
mention  the  names  of  'these  substances  as  stated  In  .Tables 
I  and  II  of  the Annex; 
Operators 
scheduled 
Involved 
substances 
In  the 
shall 
placing 
keep 
on  the  market  of 
deta II ed  commercial 
records  necessary  to  fulfil  the  obligations  under  point 
with  regard  to  these activities; 
The  documents  and  records  referred  to  In  points  and  3 
shall  be.  kept  for  a  per lod  not  less  than  two  years  from 
the  end  of  the  calendar  year  In  which  the  operation 
referred  to  In  point  took  place,  and  sha II  be  made 
readily  available  to  the  competent  authorities  upon 
request. - 8  -
Article 3 
In  order  to  ensure  the  adoption  of  appropriate  regulatory 
decisions  concerning  the  manufacture  of  Table  products  as  set 
out  In  the  Annex  and  the  placing  on  the  market  of  the  scheduled 
substances,  Member  States shall  designate  a  competent  authority. 
Member  States  sha II  Inform  the  Commission  of  the  competent 
authority  thus  designated. 
1. 
Article  4 
Additional  requirements- Substances of  Table  I  of  the  Annex 
Member  States  sha II  take  a I I  approprIate  measures 
ensure  that  the  manufacturing  or  putting  Into 
circulation  In  the  Community  of  scheduled  substances 
Table  of  the  Annex  Is  subject  to  possession  of 
authorization  granted  In  accordance  with  Article  16 
Directive 75/319/EEC. 
to 
free 
of 
an 
of 
2.  Member  States  shall  take  all  appropr late  measures  to 
ensure  that  operators  holding  the  authorization  referred 
to  In  paragraph  1  shall  only  make  available  scheduled 
substances  of  Table  of  the  Annex  to  operators  who  are 
themselves  In  possession  of  the  authorization  referred  to 
ln  paragraph  1. 
• 1. 
2. 
,;  .. 
- 9  -
Article 5 
Notification 
Member 
legal 
States  sha II  take,  consistently  WIth  their  own 
necessary 
connection 
encourage 
system, 
legal 
WIth 
operators 
appropriate 
protection 
their  own 
measures 
of  Interested 
r espons I  b I I I t y 
to  Immediately  notIfy 
Including 
persons 
so  as 
the 
In 
to 
the  competent 
authorities  of  any  circumstances,  such  as  unusual  orders 
Indicate  and  transactions  of  scheduled  substances,  which 
that  such  substances  to  . be  ··-placed  on  the  market  or 
manufactured,  as  the  case  may  be,  are  Intended  to  be 
diverted  for  the  Illicit  manufacture  of  narcotic  drugs  or 
psychotropic  substances. 
In  add It I  on  ·  to  the  measures  to  be  taken  under 
paragraph  1, 
theIr  own 
the  necessary 
Member 
legal 
legal 
States 
system, 
sha II  take, 
appropriate 
.co~slstently  with 
measures  Including 
protection  of  Interested  persons  In 
to  connection 
encourage 
obtained 
scheduled 
on  the 
Intended 
narcotic 
.l 
WIth  their  .own  respons I  b I I I  ty.  so  as 
persons  who'  suspect,  as  a  result  of  Information 
by  virtue  of  their  professlona!  .activities,  that 
substances  whIch  have  been  or  are. ,  to  be  pI aced 
··.··; 
market  or  manufactured,  as  the  . case ·  ·may  be,  are 
to  be  diverted  for  the  II licit  manufacture  of  a 
drug  or  psychotropic  substance,  t_o  Inform  the 
competent  authorities accordlngJy. - 10  -
II ILE  I I I 
Ueasures of  control 
Article 6 
Legal  powers  of  competent  authorities 
1.  In  order  to  ensure  the  correct  application  of  Articles  2, 
2. 
4  and  5,  Uember  States  shall  adopt,  consistently  WIth 
their  own  legal  system,  the  measures  necessary  to  a I low 
the  competent  authorities  : 
(a)  to  obtain  Information  on  any  orders  or  transactions 
of  scheduled  substances; 
(b)  to  enter  and  search  professional  premises  of 
(C) 
operators and  to obtain evidence of  Irregularities; 
to  seize  any 
sufficient  evidence 
been  or  Is  to 
scheduled  substance  If 
that 
be 
such 
placed 
substance, 
on  the 
there 
which 
market 
Is 
has 
or 
manufactured,  as  the  case  may  be,  Is  Intended  to  be 
used  In  the  I I I lclt  manufacture  of  a  narcotic  drug 
or  psychotropic substance. 
WIthout  prejudice  to  the  measures  laid  down  In 
Article  4( 1)  and  (2)  and  Article  6( 1)'  the  competent 
authorities  of  Uember  States  may  prohibit  the  placing  on 
the  market  or  manufacture,  as  the  case  may  be,  of 
scheduled  substances,  If  there  are  reasonable  grounds  to 
be I I  eve  that  these  substances  are  ultimately  destined  for 
the  IllIcIt  manufacture  of  narcotic  drugs  or  psychotropic 
substances. For  the  purposes 
Regulation  CEEC) 
- 11  -
TITLE  IV 
Administrative cooperation 
of 
No 
Article 7 
applying 
1468/81 
this  Directive. 
sha II  be 
the  provisions  of 
app !!cable  mutatis 
mutandis,  In  particular  the  provisions  on  confidentiality.  Each 
Member  State  shall  communicate  to  the  other  Member  States  and  to 
the  Commission  particulars  of  the  competent  authorities 
·appointed  to  · act - · as  · · correspondents  · wIth 1  n  .the  ·.  ·mean I  rig  .·of 
Article  2(2)  of  Regulation  (EEC)  No  1468/81. 
TITLE  V 
Final  provisions 
Article 8 
Member  States  sha II  determine.,  the  sanctions  to .•':be  applied 
the  lnfr lngement  of  the  provisions  of  this<'  Directive. 
for 
The 
penalties  shall  be  sufficient  to  promote  compll~nce  with  those 
provisions. 
1. 
Article 9 
The  competent  authorities  of  Member  States  shal I 
communicate  to  the Commission 
annually 
the  . amounts  of 
known,  their origin; 
scheduled  substances 
any  substance  not  Included  In  the 
Identified  as  having  been  used  In 
of  narcotic  drugs  or  psychotropic 
which  Is  deemed  to  be  sufficiently 
brought  to  the  attention  of 
Narcotics Control  Board; 
seized  and,  when 
Annex  which  Is 
llllcl t  manufacture 
substances,  and 
sIgn If  I  cant  to  be 
the  International 2. 
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methods  of  diversion  and  II licit manufacture. 
the  nature  of  processing  equipment  seized 
known,  Its origin. 
and  where 
The  Commission,  on  the  basis  of  the  communications  made 
pursuant  to  paragraph  1,  sha II,  In 
Member  States,  draw  up  an  annual  report 
to  the  International  Narcotics Control  Board. 
Article  10 
consultation  with 
to  be  submItted 
Member  States  shall  adopt  all  the  provisions  necessary  to 
1991 .  They  comply  with  this  Directive  before  1  July 
shal I  forthwith  Inform  the Commission  thereof. 
When  Member  States  adopt  these  provIsIons,  they  sha I I 
contain  a  reference  to  this  Directive  or  shall  be 
accompanied  by  such  reference  at  the  t lme  of  their 
official  publ lcatlon.  The  procedure  for  such  reference 
shall  be  adopted  by  Member  States. 
Article  11 
This  Directive  Is  addressed  to  the  Member  States. 
Done  at  Brussels,  For  the  Counc I I - 13  -
ANNEX 
TABLE  I  CAS  Number 
Ephedrine  299-42-3 
Ergometrine  60-79-7 
Ergotamine  113-15-5 
Lysergic  acid  82-58-6 
1-phenyl-2-propanone  103-79-7 
Pseudoephedrine  90-82-4 
TABLE  II  CAS  Number 
Acetic  Anhydride  108-24-7 
Acetone  67-64-1 
Anthranilic acid  118-92-3 
Ethyl  ether  60-29-7 
Phenylacetic  acid  103-82-2 
Piperidine  110-89-4 
The  salts of  the  substances 
1 lsted  In  these  tables whenever 
the  existence of  such  salts 
Is  possible 
TABLE  Ill 
Acetic  Anhydride 
Acetone 
Anthranl I lc  acid  and  Its salts 
Ethyl  ether 
Phenylacetic acid  and  Its salts 
Plperdine  and  Its salts 
I I 
EINECS  Number 
206-080-5 
200-485-0 
204-023-9 
201-431-9 
203-144-4 
202-018-6 
EINECS  Number 
203-564-8 
200-662-2 
204-287-5 
200-467-2 
203-148-6 
203-813-0 
Threshold  J  I 
1  I ltre 
1  I ltre 
100  grams 
1  I ltre 
200  grams 
0,25  I ltre - 14  -
Financial  Statement 
In  respect  of  the  proposal  for  a  directive  on  the 
manufacture  and  the  placing  on  the  market  of  certain 
substances  used  In  the  I II lett  manufacture  of  narcotic  drugs 
a n d  p.s y c hot  r o p I c  subs  t an  c e s . 
1.  Budget  headings 
2.  Legal  basts 
Ulsslon  expenses 
Ueetlngs  In  general 
Art  100  A  of  the  EEC  Treaty. 
3.  Description  of  the  action 
3.1.  General  objectives 
Implementation  of  common  measures  on  the  monitoring  and 
control  of  certain  chemical  products  In  order  to 
prevent  their  dlv~rslon to  I I I lett  drug  manufacture. 
3.2.  Specific obJectives 
a)  Introduction  of  a  system  of  monitoring  through 
specific  documentation  requirements  on  al 1  but 
sma.rt  retat r  transactions 
·  .. 
·.~· 
·· .. .  L 
b)  an  extentlon 
pharmaceutical 
Table  I 
of·  the 
authorization 
..  1 "·  ·-
e~lstlng  system  of 
to  products  of  Anne.x 
c)  to  fulfil  periodic  reporting  requlrements""'towards 
the  competent  bodies  of  the  UN. 
4.  Reasons  for  the  action 
To  fu If I I 
monitoring 
convention. 
the  standard  reQuirements  on  precursor 
that  are  contained  In  Art.  12  or  UN 
Com m  u n I t y  h a s  t o  en  a c t  I e g I s I a t l.o n  o f  t h e 
Internal  aspects  of  precursor  monitoring  to  complement 
the  legislation  already  proposed  for  external  trade  and 
at  the  same  time  to  avoid  Member  States  taking 
Individual  legislation  Incompatible  with ·the  obJectives 
of  the  Single  Market. 
5.  Financial  Impact 
5. 1.  Genera I 
The  main  financial  Impact  of  these  proposals  wl  11  fa I 1 
In  the  following  areas  : 
- t he  p e r I o d I c  or  g an I sa t I on  o f  me e t  I n g s  w I t h  ,Me m  be r 
States'  experts  In  order  to  continually  monitor  the 
correct  working  of  the  system 
-the  set-up,  at  Commission  level,  of  a  management 
structure  ensuring  llason  with  Member  States,  third 
countries  and  competent  International  organisations, 
In  particular  the  UN  and  concerned  Industry 
associations 
- drawing  up  guidelines  (on  I abe I  I  I ng,  on  good 
distribution  practice,  on  the  treatment  of  mixtures, 
extentlon  to  other  precursor  chemicals)  and  report  to 
the  competent  bodies  of  the  UN. - 16  -
5.2.  Specific  financial  Impact 
a)  Staff 
Th~  staffing  requirements  for  carrying  out  the 
specific  tasks  described  above  are  calculated  as 
follows  for  the  estimation  of  the  expenses  of 
personne.l  for  Part  A  of  the  Budget 
from  1991 
from  1992  93 
1  a s s I s t a n t  (B  5 ) 
1  administrator  (A7) 
1  secretary  (C5) 
The  staffIng  requIrements  shown  above  must  be  met 
either  by  Internal  redeployment  or  under  the 
budgetary  procedure  for  the  relevant  years,  In  the 
context  of  the  Commission  decision  on  the 
programmatlon  of  resources. 
The  spec I f  I c  t as  lc s  to  be  p e r formed  I· n c I u de 
-collection, 
Information 
circulation  and 
supp 1 1  ed  by 
Industry  associations 
management  of 
t.tember  States 
-drawing  up  of  guidelines  with  regard  to 
the  labelllng,·part.lcularly  of  mixtures 
good  distribution  practice 
the 
and 
extending  the  I 1st  of  precursor 
mixtures  and  processing  equipment, 
chemicals, 
requiring 
special  monitoring 
-drawing  up  of  a  report. on  the 
origin  of  precursor  chemicals 
seized  to  the  competent  UN  bodies. 
quantlt·les  and 
and  equipment '' 
.:·,. 
: 
. I 
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Est lmat lon  of  the  attr lbut lon  of costs ·Of  personnel ·to  part 
A of  the  budget  Is  as  follows 
76.000  ecu  In  1991 
228.000  ecu  In  1992  and  1993 
b)  Allowance  for  additional  meetings 
A  250 
Two  meetings  per  year  of  Member  States'  experts 
1991  ECU  18.000 
1992  ECU  18.000 
1993  ECU  18.000 
TOTAL  ECU  54.000 
C)  Allowance  for 
Missions  (A  130) 
,  .. 
; 
1991  ECU  6.000 
1992  ECU  6.000 
1993  ECU  6.000 
TOTAL  ECU  18~000 
r . Competitiveness  and  emplo~ment  Impact  statement 
Proposa I  for  a 
Council  Directive  (EEC) 
on  the  manufacture  and  the  placing  on 
the  market  of  certain  substances  used  in  the 
Illicit manufacture  of  narcot lc  drugs  and 
psychotropic  substances 
1.  What  Is  the  main  reason  for  Introducing  the  measures  ? 
The  general  objective  Is  to  comply  with  International 
obligations  resL•Itlng  from  Art.  12  of  the  1988  UN 
Convention  against  Illicit  Traffic  of  Narcotic  Drugs 
and  Psychotropic  Substances  signed  by  the  Community  on 
8  June  1989.  The  specific  purpose  of  the  proposal  is 
to  prevent  the  diversion  of  precursor  chemicals  to 
I  I  1 1 c I  t  manufacture  of  d r u.g s  by  est a b I  i s h i n g  i.l  s y::; t em 
of  monitoring  of  al  transact Ions  CXCtlpt  minor 
quantities  sold  at  retail  level  in  such  chemicals.  Fo1 
the  most  sensitive  chemicals  of  Table  I,  a  system  of 
all thor i 7.'H ion  t 0.  ,.., ...  ,,. ihott ion  is 
foreseen. 
1 i  Features  of  the  business  In  quest ion 
measures  apply  to  chemical 
traders, 
antl  p  t1  <1  r rn a c e u t  1 c :1  ! 
companies  as  well  as  dealers  i.lnd  broker~~ 
Involved  In  the  marketing  and  distribution  aspects. 
1 I  1 .  W  h a t  d  i r e c t  o b  I  I g a t  I on s  doe s  t n I s  me a s u r e  1  ':f1.2_?_:;_e__£_;_~ 
business  7 
Economic  operators  concerned  with  precursor  chemicals 
rn Ll  ~:;  t  k e e p  f o r  a t  I e a s t  2  c a I e n d a r  y e a r s  f  r o rn  a J  t  e  o t 
transact ion  readily  available  commercial  records. 
F u r  t  II e r rn or n  t ll o so  I n v o  I v e d  w I  t h  :} u b s t an c,:  ~~  i n  T ;dJ 1  0 
..1  r  ~J  r e q u  i  r e d  t o  b e  I n  p o s ~ e s s I o n  o f  a n  ::1 u t h o r  i  ;- :1  t  I o n 
J  c c '-' r d b  d  t C>  n  h a r m  a c e u t  I c a I  e n t e r p r  I s e s . 
/ 
·, ,j 
'I 
'! .. 
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·s:;:ce  tht:l  nvnr~helmlnq proportion  of  transactions  related  to 
Table  substance  Is  In  any  case  by  and  be tween 
philrmacouticai  enterprises  this  would  not  impose  In  general 
a  new  o b I  I g a t  I on  but  an  ex ten tJ on  of  t he  ex I s t  I n g  system . · 
IV .  What  Indirect  obligations  are  local  authorlt·tes  likely 
to  Impose  on  bus 1  ness  7 
None  foreseen 
Y..  Are·  there  any.  special  measures  In  respects  of  SMEs  7 
No 
VI.  ·What  Is  thA  likely  effect  on 
a)  Competltlvlness  of  business  7 
None 
b)  omployment  7 
None 
VI 1.  Have  both  sides  of  Industry  be  consulted  on 
~~~~~~--~~~--~------------~----------~~------~------
the 
proposals  7 
Following  Interested  parties  were  consulted 
-associations  of  chemical  Industry 
-associations  of  pharmaceutical  Industry 
-associations  of  chemical  traders ISS\' 0.254-1475 
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